Press Releases

Press Releases

Ligand Pharmaceuticals Incorporated announces it has entered into a global license and supply agreement with Sanofi to utilize Captisol in the development and commercialization of SAR-125844, a potent MET kinase inhibitor. Under the terms of the license, Ligand will be eligible to receive potential milestone payments, royalties on future net…

Press Releases

NovaBay Pharmaceuticals, Inc., a biopharmaceutical company commercializing and developing topical non-antibiotic antimicrobial products for the global eye care market, today announced that it will report second quarter financial results after market close on Thursday, August 13. Management will hold an investment community conference call to discuss financial results and provide…

Press Releases

Now in its 13th year, and supported by the Indian Pharmaceutical Associaton, join big pharma players, biotechs, biotech entrepreneurs, key stakeholders including BIRAC, CDSCO and NII, solution providers and associations, from both within India and across the globe at the BioPharma India Convention 2015.  Happening at The Westin Mumbai Garden…

Press Releases

ZS Pharma, Inc., today announced that its New Drug Application (NDA) for ZS-9 (sodium zirconium cyclosilicate) for the treatment of hyperkalemia, has been accepted for filing by the United States Food and Drug Administration (FDA). We have been informed that the Prescription Drug User Fee Act (PDUFA) goal date for…

Press Releases

Medivir AB today announces the start of a phase I clinical trial with AL-704, also known as JNJ-54257099, by Alios Biopharma Inc., part of the Janssen Pharmaceutical Companies. AL-704 is a nucleotide based NS5B polymerase inhibitor intended for the treatment of chronic hepatitis C virus (HCV) infection in combination with…

Press Releases

The Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, also known as the Sabin product development partnership (Sabin PDP), a major research component of the National School of Tropical Medicine at Baylor College of Medicine, received a grant of $1.8 million from the Robert J. Kleberg, Jr.…

Press Releases

PD-Rx Pharmaceuticals, Inc., a publicly held corporation, today announced that it has partnered with Dobson Technologies, a fully-integrated outsourced IT provider, for their Infrastructure as a Service (IaaS) product. PD-Rx is an Application Service Provider (ASP) to medical practices across the United States.  Using Dobson Technologies' IaaS solution will allow…

Press Releases

Cumberland Pharmaceuticals Inc. announced today that it will release second quarter 2015 financial results after the market closes on Tuesday, August 4, 2015.  A conference call and live Internet webcast will be held on Tuesday, August 4, 2015, at 4:30 p.m. Eastern Time to discuss the results. To participate in…

Press Releases

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it will report financial results and highlights for the quarter ended June 30, 2015 on Tuesday, August 4, 2015, after the U.S. financial markets close. Regulus will host a conference call…

Press Releases

Otic Pharma Ltd, a privately held pharmaceutical company focused on developing innovative therapies for ear, nose, and throat disorders, today announced the appointment of Gregory J. Flesher as chief executive officer and member of the company's board of directors. Mr. Flesher brings more than 20 years of drug development and…